According to filings with the U.S. Securities and Exchange Commission, PatientFi is raising up to $15,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About PatientFi
PatientFi is modernizing healthcare financing with a smarter, more patient friendly way to pay for elective treatments. Through its nationwide partnership network of medical practices, PatientFi offers real-time, point-of sale financing that eliminates the friction of affordability. We serve a broad network of healthcare specialties, including plastic surgery, dermatology, ophthalmology, dentistry, fertility, audiology and medical spas. Our mission is to expand patient access to elective healthcare treatments by removing the cost barrier and offering patients a friendly way to pay.

To learn more, visit https://patientfi.com/
LinkedIn: https://www.linkedin.com/company/patientfi/

Contact:
Todd Watts, Chief Executive Officer
https://www.linkedin.com/in/towatts/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.